Is there a correlation between Tumor Necrosis Factor α and soluble p-55 receptor plasma levels in advanced gastrointestinal cancer patients?

Journal of Biological Regulators and Homeostatic Agents

Volumn 10, Issue 4, 1996, Pages 95-97

  Muc Wierzgon M ^a,c   Madej, K ^a   Baranowski, M ^a   Wierzgon J ^b  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

^c 5th Department of Internal Medicine   (Poland)

Author keywords

Advanced cancer; Endogenous TNF alpha; Rhythmicity; Soluble TNF Rp55

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD LEVEL; CIRCADIAN RHYTHM; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; FEMALE; HUMAN; LIGAND BINDING; MAJOR CLINICAL STUDY; MALE; PROTEIN INDUCTION; PROTEIN SECRETION;

EID: 0030364474     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Beutler B, Cerami A. Tumor necrosis, cachexia, shock and inflammation: a common mediator. Annu Rev Biochem 1988, 57: 505-18.
2. Tartaglia LA, Goeddel DV Two TNF receptors. Immunol Today 1992; 13: 151-3.
3. Hohman HP, Remy R et al. Two different cell types have different major receptors for human tumor necrosis factor. J Biol Chem 1989; 264: 14927-34.
4. Seeking P, Isaaz S et al. Purification and biologic characterization of a specific tumor necrosis factor inhibitor. J Biol Chem 1989; 264: 11966-73.
5. Diez-Ruiz A, Tilz GP et al. Soluble receptorsr for tumor necrosis factor in clinical laboratory diagnosis. Eur J Haematol 1995; 54: 1-8.
6. Aderka D, Engelmann H et al. Increased serum levels of soluble recptors for tumor necrosis factor in cancer patients. Cancer Res 1991; 51: 5602-7.
7. Muc-Wierzgoń M, Madej K, Baranowski M. Fluctuation of endogenous TNF alpha concentration in plasma in advanced cancer patients. J Biol Reaul Homeost Agents 1996, 10 (1): 25-6.
8. Muc-Wierzgoń M, Madej K., Baranowski M. Diurnal rhythmicity of endogenous TNF alpha concentration in plasma of advanced gastrointestinal cancer. Oncol Repp 1997 (in press).
9. Olsson I, Gatanaga T et al. Tumor necrosis factor binding proteins (soluble TNF receptor forms) with possible roles in inflammation and malignancy. Eur Cytokine Netw 1993; 4: 169-80.
10. Grossen EA, Granger GA et al. Measurement of the soluble membrane receptors for tumor necrosis factor and lymphotoxin in the sera of patients with gynaecologic malignacy. Gynecol Oncol 1993; 50: 68-77.
11. Langkopf F, Atzpodien J. Soluble tumor necrosis factor receptors as prognostic factors in cancer patients. Lancet 1994; 344: 57-8.